Melting point	229-231 ºC

Symbol(GHS)	Xn
Hazard Codes	R22

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Mutagenicity of the coccidiostat diaveridine in the Salmonella/mammalian microsome assay.H Yoshimura Mutation research, 261(2), 149-152 (1991-10-01) Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.P D Walzer et al.Antimicrobial agents and chemotherapy, 32(1), 96-103 (1988-01-01) A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect.G Gigler et al.Agents and actions. Supplements, 32, 39-43 (1991-01-01) Mutagenic activity and mutational specificity of antiprotozoal drugs with and without nitrite treatment.Tomoko Ono-Ogata et al.Environmental and molecular mutagenesis, 39(1), 43-48 (2002-01-29) Determination of residual diaveridine and sulfaquinoxaline in Hen's egg, chicken plasma and tissues by high-performance liquid chromatography.T Sakano et al.Chemical & pharmaceutical bulletin, 29(8), 2290-2295 (1981-08-01) [Effect of sulfaquinoxaline and diaveridine on leucocytozoon infection in chickens].A Tanabe et al.Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 86(6), 411-415 (1985-12-01) [Polarographic determination of diaveridine in biological samples].P Tömpe et al.Acta pharmaceutica Hungarica, 60(1), 23-29 (1990-01-01) Residue Reviews: Residues of Pesticides and Other Contaminants in the Total Environment (2012) Characterization of in vitro metabolites of trimethoprim and diaveridine in pig liver microsomes by liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.Zhao-Ying Liu et al.Biomedical chromatography : BMC, 26(9), 1101-1108 (2011-12-14) Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.D S Lindsay et al.American journal of veterinary research, 57(1), 68-72 (1996-01-01)

Remarks